Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emergent BioSolutions
Pharma
NIH study shows mpox shot elicits immune response in teens
Interim results of an NIH trial of Bavarian Nordic's Jynneos indicate that it is safe and elicits an immune response in teens.
Kevin Dunleavy
Oct 17, 2024 11:17am
Emergent BioSolutions' mpox preparedness orders reach $400M
Sep 25, 2024 1:06pm
Emergent's smallpox vaccine wins FDA approval for mpox
Aug 30, 2024 11:23am
Emergent pledges smallpox vax doses to help fight mpox in Africa
Aug 20, 2024 10:25am
Emergent, ex-NFL star show how to tackle opioid overdoses
Jul 24, 2024 10:55am
US renews $113M deal with Siga to supply mpox antiviral Tpoxx
Jul 19, 2024 10:35am
